The selection of the breast cancer cell line MDA-MB-231 was because human breast adenocarcinoma MBA-MD-231 cells express higher levels of pyruvate kinase M2 isoform (PKM2) when compared to MCF-7 cells. This evidence concerns the gene PKM and breast carcinoma.